{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:54:41Z","timestamp":1773762881840,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Foundation","doi-asserted-by":"crossref","award":["NIH R01HL093172"],"award-info":[{"award-number":["NIH R01HL093172"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Foundation","doi-asserted-by":"crossref","award":["NIH R01HL095571"],"award-info":[{"award-number":["NIH R01HL095571"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Foundation","doi-asserted-by":"crossref","award":["NIH R33 HL089027"],"award-info":[{"award-number":["NIH R33 HL089027"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Foundation","doi-asserted-by":"crossref","award":["NIH R01EB009689"],"award-info":[{"award-number":["NIH R01EB009689"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.tcm.2012.08.009","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T01:01:49Z","timestamp":1355360509000},"page":"39-45","source":"Crossref","is-referenced-by-count":57,"title":["Advances in nanotechnology for the management of coronary artery disease"],"prefix":"10.1016","volume":"23","author":[{"given":"June-Wha","family":"Rhee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2012.08.009_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/4501117a","article-title":"Small RNAs: delivering the future","volume":"450","author":"Blow","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2012.08.009_bib2","first-page":"143","article-title":"Nanoparticulate carriers for the treatment of coronary restenosis","volume":"2","author":"Brito","year":"2007","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/FJC.0b013e3181624aed","article-title":"Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin","volume":"51","author":"Broz","year":"2008","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.tcm.2012.08.009_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.tcm.2012.08.009_bib5","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1016\/j.biomaterials.2011.08.018","article-title":"Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface","volume":"32","author":"Ceylan","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.tcm.2012.08.009_bib6","doi-asserted-by":"crossref","first-page":"19347","DOI":"10.1073\/pnas.1115945108","article-title":"In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles","volume":"108","author":"Chan","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tcm.2012.08.009_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1258\/ebm.2010.009320","article-title":"Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits","volume":"235","author":"Cho","year":"2010","journal-title":"Experimental Biology and Medicine (Maywood)"},{"key":"10.1016\/j.tcm.2012.08.009_bib8","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1073\/pnas.0909506107","article-title":"Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields","volume":"107","author":"Chorny","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tcm.2012.08.009_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/01.CIR.0000023532.98469.48","article-title":"Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits","volume":"106","author":"Danenberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2012.08.009_bib10","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1161\/01.CIR.0000097002.69209.CD","article-title":"Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits","volume":"108","author":"Danenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2012.08.009_bib11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.tcm.2012.08.009_bib12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.addr.2006.09.011","article-title":"Nanomedicine: developing smarter therapeutic and diagnostic modalities","volume":"58","author":"Farokhzad","year":"2006","journal-title":"Advanced drug delivery reviews"},{"key":"10.1016\/j.tcm.2012.08.009_bib13","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0704581104","article-title":"Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts","volume":"104","author":"Hashi","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tcm.2012.08.009_bib14","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.108.170662","article-title":"Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma","volume":"28","author":"Joner","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2012.08.009_bib15","first-page":"733","article-title":"Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions","volume":"44","author":"Kipshidze","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.tcm.2012.08.009_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.0000032141.31476.15","article-title":"Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel","volume":"106","author":"Kolodgie","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2012.08.009_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.biomaterials.2009.10.051","article-title":"A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices","volume":"31","author":"Kushwaha","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.tcm.2012.08.009_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0021-9150(99)00499-2","article-title":"Serum levels of high-density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease","volume":"152","author":"Lan Hsia","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2012.08.009_bib19","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1161\/01.CIR.0000044020.27990.32","article-title":"Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis","volume":"106","author":"Lanza","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2012.08.009_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nature Biotechnology"},{"issue":"Suppl. 1","key":"10.1016\/j.tcm.2012.08.009_bib21","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.2967\/jnumed.109.069633","article-title":"The vascular biology of atherosclerosis and imaging targets","volume":"51","author":"Libby","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2012.08.009_bib23","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/mp100309y","article-title":"Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis","volume":"7","author":"Lobatto","year":"2010","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.tcm.2012.08.009_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.20066","article-title":"Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study","volume":"30","author":"Margolis","year":"2007","journal-title":"Clinical Cardiology"},{"key":"10.1016\/j.tcm.2012.08.009_bib25","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/smll.201000596","article-title":"A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis","volume":"6","author":"McCarthy","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.tcm.2012.08.009_bib26","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2012.08.009_bib27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1538-7836.2011.04339.x","article-title":"Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis","volume":"9","author":"Myerson","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2012.08.009_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcin.2011.11.013","article-title":"Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent","volume":"5","author":"Pendyala","year":"2012","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1016\/j.tcm.2012.08.009_bib29","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.0903369106","article-title":"Targeting atherosclerosis by using modular, multifunctional micelles","volume":"106","author":"Peters","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tcm.2012.08.009_bib30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1073\/pnas.0708338105","article-title":"High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents","volume":"105","author":"Polyak","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tcm.2012.08.009_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0021-9150(00)00605-5","article-title":"Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits","volume":"155","author":"Poon","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2012.08.009_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/wnan.1166","article-title":"Development of tissue engineered vascular grafts and application of nanomedicine. Wiley interdisciplinary reviews","volume":"4","author":"Rathore","year":"2012","journal-title":"Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.tcm.2012.08.009_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib36","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.biomaterials.2007.02.012","article-title":"Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization","volume":"28","author":"Stankus","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.tcm.2012.08.009_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/17435889.2.4.415","article-title":"Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel","volume":"2","author":"Stinchcombe","year":"2007","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.tcm.2012.08.009_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2012.08.009_bib39","first-page":"624","article-title":"Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis","volume":"1","author":"Winter","year":"2008","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2012.08.009_bib40","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","article-title":"Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis","volume":"26","author":"Winter","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173812003015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173812003015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T02:59:01Z","timestamp":1540004341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173812003015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1050173812003015"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2012.08.009","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}